Light therapy modality

• US 8,790,383 B2
• Filed: 05/17/2013
• Issued: 07/29/2014
• Est. Priority Date: 03/29/2011
• Status: Active Grant

• Current Assignee: Valkee Oy
• Original Assignee: Valkee Oy
• Inventors: Aunio, Antti, Nissila, Juuso
• Primary Examiner(s): Thomson, William
• Assistant Examiner(s): LIPITZ, JEFFREY BRIAN
• Application Number:
  US13/896,673
• Publication Number:
  US 20130253618A1
• Time in Patent Office: 438 Days
• Field of Search: 607 88- 93, 351/51
• US Class Current: 607/89
• CPC Class Codes: A61N 2005/0605 Ear
• CPC Class Codes: A61N 2005/0647 the applicator adapted to be worn on the head
• CPC Class Codes: A61N 2005/0662 Visible light
• CPC Class Codes: A61N 5/0618 Psychological treatment
• CPC Class Codes: A61N 5/0622 Optical stimulation for exciting neural tissue

Abstract

A method of light therapy includes non-invasive, intra-cranial administration of bright light via the ear canal of a subject by using a light intensity of 0.7-12 lumens, and a treatment time of 1-15 minutes. A medical device including radiation elements for directing the light via the ear canal for use in the light therapy is described.

Claims

1. A medical device for treating a subject for depression, the medical device comprising:

radiation means for directing light directly into an ear canal of the subject suffering from depression, the radiation means including at least one phosphorus-based white light emitting diode (“

LED”

) having a primary peak wavelength in the range of 450-475 nm and a secondary peak wavelength in the range of 495-570 nm;

adapter means for arranging the radiation means in an external ear of the subject to enable administration of light via the ear canal; and

a controller unit for adjusting bright light administration and optical radiation provided to the ear canal by the radiation means.

2. The medical device of claim 1, wherein a power intensity in the primary peak wavelength range is substantially 50% higher than a power intensity in the secondary peak wavelength range.

3. The medical device of claim 2, wherein the power intensity in the primary peak wavelength range is about 1.5E-04 W/nm and the power intensity in the secondary peak wavelength range is about 1.0E-04 W/nm.

4. The medical device of claim 1, wherein the radiation means consists of one LED per ear canal of the subject.

5. The medical device of claim 4, wherein each LED is inserted directly into a corresponding ear canal.

6. The medical device of claim 1, wherein the radiation means directs light having an intensity in the range of 3-10 lumens directly into the ear canal of the subject.

7. The medical device of claim 1, wherein the subject is in need of light therapy for prevention of migraine headaches, the light therapy is administered once per day, and wherein the controller unit controls the radiation means to administer a daily light therapy application to the subject directly via the ear canals for a time period in the range of 6-12 minutes, the light having a power intensity in the primary peak wavelength range which is larger than a power intensity in the secondary peak wavelength range.

8. The medical device of claim 6, wherein the daily light therapy application is in the range of 3-10 lumens.

9. The medical device of claim 7, wherein the light of the daily light therapy application has visible light spectrum properties imitating light spectrum properties of natural sunlight.

10. The medical device of claim 7, wherein a power intensity in the primary peak wavelength range is substantially 50% higher than a power intensity in the secondary peak wavelength range.